Autoantibodies against complement C1q in patients with Behcet’s disease: association with vascular involvement

References

• Chen M, Daha MR, Kallenberg CG. The complement system in systemic autoimmune disease. J Autoimmun. 2010;34(3): J276–J286.
   PubMed Web of Science ®Google Scholar
• Sturfelt G, Truedsson L. Complement in the immunopathogenesis of rheumatic disease. Nat Rev Rheumatol. 2012;8(8): 458–468.
   PubMed Web of Science ®Google Scholar
• Kallenberg CG. Anti-C1q autoantibodies. Autoimmun Rev. 2008;7(8): 612–615.
   PubMed Web of Science ®Google Scholar
• Stoyanova V, Petrova S, Tchorbadjieva M, Deliyska B, Vasilev V, Tsacheva I. New insight into the autoimmunogenicity of the complement protein C1q. Mol Immunol. 2011;48(4): 678–682.
   PubMed Web of Science ®Google Scholar
• Tsirogianni A, Pipi E, Soufleros K. Relevance of anti-C1q autoantibodies to lupus nephritis. Ann N Y Acad Sci. 2009;1173: 243–251.
   PubMed Web of Science ®Google Scholar
• Yin Y, Wu X, Shan G, Zhang X. Diagnostic value of serum anti-C1q antibodies in patients with lupus nephritis: a meta-analysis. Lupus. 2012;21(10): 1088–1097.
   PubMed Web of Science ®Google Scholar
• Brown NA, John D. Carter JD. Urticarial vasculitis. Curr Rheumatol Rep. 2007;9(4):312–9.
   PubMedGoogle Scholar
• Hatemi G, Seyahi E, Fresko I, Hamuryudan V. Behçet’s syndrome: a critical digest of the recent literature. Clin Exp Rheumatol. 2012;30(3 Suppl 72): S80–S89.
   PubMed Web of Science ®Google Scholar
• Yazici Y, Yurdakul S, Yazici H. Behcet’s syndrome. Curr Rheumatol Rep. 2010;12(6): 429–435.
   PubMedGoogle Scholar
• Bardak Y, Aridoğan BC. The demonstration of serum interleukin 6–8, tumor necrosis factor-alpha, complement, and immunoglobulin levels in Behçet’s disease with ocular involvement. Ocul Immunol Inflamm. 2004;12: 53–58.
   PubMed Web of Science ®Google Scholar
• Tüzün E, Kürtüncü M, Türkoğlu R, Içöz S, Pehlivan M, Birişik O, et al. Enhanced complement consumption in neuromyelitis optica and Behçet’s disease patients. J Neuroimmunol. 2011;233(1–2): 211–215.
   PubMed Web of Science ®Google Scholar
• Al-Mutawa SA, Hegab SM. Behcet’s disease. Clin Exp Med. 2004;4: 103–131.
   PubMed Web of Science ®Google Scholar
• Mendoza-Pinto C, García-Carrasco M, Jiménez-Hernández M, Jiménez Hernández C, Riebeling-Navarro C, Nava Zavala A, et al. Etiopathogenesis of Behcet’s disease. Autoimmun Rev. 2010;9(4): 241–245.
   PubMed Web of Science ®Google Scholar
• International Study Group for Behcet’s disease. Criteria for diagnosis of Behcet’s disease. Lancet. 1990;335: 1078–1080.
   PubMed Web of Science ®Google Scholar
• Choe JY, Park SH, Kim SK. Serum angiopoietin-1 level is increased in patients with Behçet’s disease. Joint Bone Spine. 2010;77(4): 340–344.
   PubMed Web of Science ®Google Scholar
• Potlukova E, Kralikova P. Anti-C1q antibodies in theory and in clinical practice. Scand J Immunol. 2008;67(5): 423–430.
   PubMed Web of Science ®Google Scholar
• Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, et al. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Scand J Rheumatol. 2007;36(4): 291–298.
   PubMed Web of Science ®Google Scholar
• Sinico RA, Rimoldi L, Radice A, Bianchi L, Gallelli B, Moroni G. Anti-C1q autoantibodies in lupus nephritis. Ann N Y Acad Sci. 2009;1173: 47–51.
   PubMed Web of Science ®Google Scholar
• Horváth L, Czirják L, Fekete B, Jakab L, Prohászka Z, Cervenak L, et al. Levels of antibodies against C1q and 60 kDa family of heat shock proteins in the sera of patients with various autoimmune diseases. Immunol Lett. 2001;75(2): 103–109.
   PubMed Web of Science ®Google Scholar
• Akhter E, Burlingame RW, Seaman AL, Magder L, Petri M. Anti-C1q antibodies have higher correlation with flares of lupus nephritis than other serum markers. Lupus. 2011;20(12): 1267–1274.
   PubMed Web of Science ®Google Scholar
• Potlukova E, Jiskra J, Limanova Z, Kralikova P, Smutek D, Mareckova H, et al. Autoantibodies against complement C1q correlate with the thyroid function in patients with autoimmune thyroid disease. Clin Exp Immunol. 2008;153(1): 96–101.
   PubMed Web of Science ®Google Scholar
• Tüzün E, Saini SS, Ghosh S, Rowin J, Meriggioli MN, Christadoss P. Predictive value of serum anti-C1q antibody levels in experimental autoimmune myasthenia gravis. Neuromuscul Disord. 2006;16(2): 137–143.
   PubMed Web of Science ®Google Scholar
• Prohászka Z, Daha MR, Süsal C, Daniel V, Szlávik J, Bánhegyi D, et al. C1q autoantibodies in HIV infection: correlation to elevated levels of autoantibodies against 60-kDa heat-shock proteins. Clin Immunol. 1999;90(2): 247–255.
   PubMed Web of Science ®Google Scholar
• Lienesch DW, Sherman KE, Metzger A, Shen GQ. Anti-Clq antibodies in patients with chronic hepatitis C infection. Clin Exp Rheumatol. 2006;24(2): 183–185.
   PubMed Web of Science ®Google Scholar
• Saadoun D, Sadallah S, Trendelenburg M, Limal N, Sene D, Piette JC, et al. Anti-C1q antibodies in hepatitis C virus infection. Clin Exp Immunol. 2006;145(2): 308–312.
   PubMed Web of Science ®Google Scholar
• Siegert CE, Kazatchkine MD, Sjöholm A, Würzner R, Loos M, Daha MR. Autoantibodies against C1q: view on clinical relevance and pathogenic role. Clin Exp Immunol. 1999;116(1): 4–8.
   PubMed Web of Science ®Google Scholar
• Gamble CN, Wiesner KB, Shapiro RF, Boyer WJ. The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Behçet’s disease. Am J Med. 1979;66(6): 1031–1039.
   PubMed Web of Science ®Google Scholar
• Navratil JS, Watkins SC, Wisnieski JJ, Ahearn JM. The globular heads of C1q specifically recognize surface blebs of apoptotic vascular endothelial cells. J Immunol. 2001;166(5): 3231–3239.
   PubMed Web of Science ®Google Scholar
• Bigler C, Schaller M, Perahud I, Osthoff M, Trendelenburg M. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells. J Immunol. 2009;183(5): 3512–3521.
   PubMed Web of Science ®Google Scholar